Literature DB >> 27757589

TRP channels: potential drug target for neuropathic pain.

Lovish Marwaha1, Yashika Bansal1, Raghunath Singh1, Priyanka Saroj1, Ranjana Bhandari1, Anurag Kuhad2.   

Abstract

Neuropathic pain is a debilitating disease which affects central as well as peripheral nervous system. Transient receptor potential (TRP) channels are ligand-gated ion channels that detect physical and chemical stimuli and promote painful sensations via nociceptor activation. TRP channels have physiological role in the mechanisms controlling several physiological responses like temperature and mechanical sensations, response to painful stimuli, taste, and pheromones. TRP channel family involves six different TRPs (TRPV1, TRPV2, TRPV3, TRPV4, TRPM8, and TRPA1) which are expressed in pain sensing neurons and primary afferent nociceptors. They function as transducers for mechanical, chemical, and thermal stimuli into inward currents, an essential first step for provoking pain sensations. TRP ion channels activated by temperature (thermo TRPs) are important molecular players in acute, inflammatory, and chronic pain states. Different degree of heat activates four TRP channels (TRPV1-4), while cold temperature ranging from affable to painful activate two indistinctly related thermo TRP channels (TRPM8 and TRPA1). Targeting primary afferent nociceptive neurons containing TRP channels that play pivotal role in revealing physical stimuli may be an effective target for the development of successful pharmacotherapeutics for clinical pain syndromes. In this review, we highlighted the potential role of various TRP channels in different types of neuropathic pain. We also discussed the pharmacological activity of naturally and synthetically originated TRP channel modulators for pharmacotherapeutics of nociception and neuropathic pain.

Entities:  

Keywords:  Drug target; Neuropathic pain; Pharmacotherapy; TRP channels

Mesh:

Substances:

Year:  2016        PMID: 27757589     DOI: 10.1007/s10787-016-0288-x

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  130 in total

Review 1.  Molecular mechanisms of nociception.

Authors:  D Julius; A I Basbaum
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

Review 2.  The TRP channels, a remarkably functional family.

Authors:  Craig Montell; Lutz Birnbaumer; Veit Flockerzi
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 3.  2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release.

Authors:  Martin D Bootman; Tony J Collins; Lauren Mackenzie; H Llewelyn Roderick; Michael J Berridge; Claire M Peppiatt
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

Review 4.  Transient receptor potential channels as therapeutic targets.

Authors:  Magdalene M Moran; Michael Allen McAlexander; Tamás Bíró; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

Review 5.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

6.  Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain.

Authors:  Mark D Andrews; Kerry Af Forselles; Kevin Beaumont; Sébastien R G Galan; Paul A Glossop; Mathilde Grenie; Alan Jessiman; Amy S Kenyon; Graham Lunn; Graham Maw; Robert M Owen; David C Pryde; Dannielle Roberts; Thien Duc Tran
Journal:  ACS Med Chem Lett       Date:  2015-01-30       Impact factor: 4.345

Review 7.  Capsaicin as a tool for studying sensory neuron functions.

Authors:  P Holzer
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

8.  Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.

Authors:  Laszlo Karai; Dorothy C Brown; Andrew J Mannes; Stephen T Connelly; Jacob Brown; Michael Gandal; Ofer M Wellisch; John K Neubert; Zoltan Olah; Michael J Iadarola
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Heat-evoked activation of the ion channel, TRPV4.

Authors:  Ali Deniz Güler; Hyosang Lee; Tohko Iida; Isao Shimizu; Makoto Tominaga; Michael Caterina
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy.

Authors:  Paul Facer; Maria A Casula; Graham D Smith; Christopher D Benham; Iain P Chessell; Chas Bountra; Marco Sinisi; Rolfe Birch; Praveen Anand
Journal:  BMC Neurol       Date:  2007-05-23       Impact factor: 2.474

View more
  33 in total

1.  An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain.

Authors:  Yong Fang Zhu; Katja Linher-Melville; Mohammad Javad Niazmand; Manu Sharma; Ayesha Shahid; Kan Lun Zhu; Natalka Parzei; Jesse Sidhu; Christeene Haj; Raphael Mechoulam; Gurmit Singh
Journal:  Br J Pharmacol       Date:  2020-03-08       Impact factor: 8.739

2.  α-Spinasterol: a COX inhibitor and a transient receptor potential vanilloid 1 antagonist presents an antinociceptive effect in clinically relevant models of pain in mice.

Authors:  Indiara Brusco; Camila Camponogara; Fabiano Barbosa Carvalho; Maria Rosa Chitolina Schetinger; Mauro Schneider Oliveira; Gabriela Trevisan; Juliano Ferreira; Sara Marchesan Oliveira
Journal:  Br J Pharmacol       Date:  2017-10-18       Impact factor: 8.739

3.  Molecular mechanisms of the analgesic action of Wu-tou Decoction on neuropathic pain in mice revealed using microarray and network analysis.

Authors:  Yan-Qiong Zhang; Chao Wang; Qiu-Yan Guo; Chun-Yan Zhu; Chen Yan; Dan-Ni Sun; Qiong-Hong Xu; Na Lin
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

4.  NIR irradiation of human buccal fat pad adipose stem cells and its effect on TRP ion channels.

Authors:  Leila Gholami; Saeid Afshar; Aliasghar Arkian; Masood Saeidijam; Seyedeh Sareh Hendi; Roghayeh Mahmoudi; Khatereh Khorsandi; Hadi Hashemzehi; Reza Fekrazad
Journal:  Lasers Med Sci       Date:  2022-10-13       Impact factor: 2.555

5.  Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat.

Authors:  Carmen De Caro; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Antonio Calignano; Andrea Aramini; Gianluca Bianchini; Marcello Allegretti; Laura Brandolini
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

6.  TRPA1 polymorphisms in chronic and complete spinal cord injury patients with neuropathic pain: a pilot study.

Authors:  Sonia Vidal Rodriguez; Inmaculada Castillo Aguilar; Luis Cuesta Villa; Francisco Serrano Saenz de Tejada
Journal:  Spinal Cord Ser Cases       Date:  2017-12-07

Review 7.  Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways.

Authors:  Lucia Hoppanova; Lubica Lacinova
Journal:  Pflugers Arch       Date:  2022-01-18       Impact factor: 3.657

8.  Suppression of TRPV1/TRPM8/P2Y Nociceptors by Withametelin via Downregulating MAPK Signaling in Mouse Model of Vincristine-Induced Neuropathic Pain.

Authors:  Adnan Khan; Bushra Shal; Ashraf Ullah Khan; Rahim Ullah; Muhammad Waleed Baig; Ihsan Ul Haq; Eun Kyoung Seo; Salman Khan
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

9.  Temperature Sensitivity After Burn Injury: A Burn Model System National Database Hot Topic.

Authors:  Jamie Oh; Christopher Madison; Grace Flott; Elisha G Brownson; Stephen Sibbett; Carolina Seek; Gretchen J Carrougher; Colleen M Ryan; Karen Kowalske; Nicole S Gibran; Barclay T Stewart
Journal:  J Burn Care Res       Date:  2021-11-24       Impact factor: 1.819

Review 10.  Evolution of nociception and pain: evidence from fish models.

Authors:  Lynne U Sneddon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.